11/12/2023 0 Comments Ortho clinical diagnostics vitros![]() This assay was originally approved by the U.S. regulatory approval for the first fully random-access, automated HIV assay (VITROS ® Anti-HIV 1+2 Assay) for the VITROS ® 3600 Immunodiagnostic System. In the future, Ortho Clinical Diagnostics plans to seek U.S. Among these world-class assays is the VITROS ® Troponin I ES Assay, which features improved sensitivity and more reliable information for patients with acute coronary syndrome and the VITROS ® Anti-HCV Assay, which features improved sensitivity to test for IgG antibody to hepatitis C virus. The broad menu of 47 1 immunoassays covers disease states including: cardiology, oncology, endocrinology, infectious disease, thyroid, metabolic conditions, and anemia. The single-use tips on the system eliminate sample and reagent carryover and automatically detect clots and bubbles to avoid reporting erroneous results. The VITROS ® 3600 Immunodiagnostic System will use the same reagents as other VITROS ® Systems, thereby maintaining the same degree of accuracy and efficiency. "We built this new high-capacity system based on a foundation of proven VITROS ® technologies to give our customers the ability to consistently produce highly accurate test results for high-volume routine immunoassays, such as cardiology, thyroid and endocrinology, and infectious disease immunoassays, such as HIV and hepatitis."Ībout the VITROS ® 3600 Immunodiagnostic Systemĭesigned with the input and feedback from a diverse group of laboratories around the world, the VITROS ® 3600 Immunodiagnostic System complements and extends the capabilities of the VITROS ® family of instruments. "The introduction of the VITROS ® 3600 Immunodiagnostic System continues our commitment to go beyond merely improving existing technologies to help clinical laboratories meet their challenges," said Ortho Clinical Diagnostics Worldwide Commercial President Mark Straley. The VITROS ® 3600 Immunodiagnostic System can be easily integrated with the enGen ™ Laboratory Automation System and other VITROS ® Systems, such as the VITROS ® 5,1 FS Chemistry System, allowing users to easily expand or change modules and interfaces as their needs change. Uettwiller-Geiger is a principal investigator for the VITROS ® 3600 Immunodiagnostic System. "The large capacity of 31 reagent packs and the ability to change reagents and consumables, as well as offload waste while the VITROS ® 3600 Immunodiagnostic System is operating, provides uninterrupted workflow to ensure we can keep up with testing demands." Dr. Mather Memorial Hospital in Port Jefferson, N.Y. The intelligent sample management capabilities of the VITROS ® 3600 Immunodiagnostic System allow users to increase productivity while maintaining high-quality test results," said Denise Uettwiller-Geiger, Ph.D., Administrative Director and Director of Clinical Research at John T. "One of the key challenges faced by diagnostic laboratories today is the need to decrease the turnaround time required to provide accurate and reliable test results to clinicians. Intellicheck ® Technology verifies analytical performance and reduces error potential by providing real-time operator notification and tracking.Īdditionally, the processing speed, on-board reagent capacities and uninterrupted workflow advantages of the system allow laboratories to address peak workloads and decrease turnaround times. ![]() This capability reduces the time, labor and error potential of manual interpretation. MicroSensor Technology automatically performs sample quality indices checks for the first time ever on an immunoassay system.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |